Skip to content
Medical Health Aged Care

Gold Coast show their support for people impacted by dementia

Dementia Australia 2 mins read

Gold Coast community members turned up in force last weekend, showing their support for people impacted by dementia whilst getting active to improve their brain health.

 

Participating in the 2025 Memory Walk & Jog at Pratten Park, Broadbeach, more than 1,030 people walked, ran and jogged to raise an impressive total of $121,400.

 

Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, raised funds, spread the word and donated.

 

“There was an outstanding show of support from the Gold Coast community who turned out in such large numbers yet again in support of people impacted by dementia,” Professor Buchanan said.

 

“It was great to see the community supporting Dementia Australia by raising funds and awareness of dementia as well as moving for their brain health, which research shows can help reduce our risk of dementia.”

 

Professor Buchanan also acknowledged everyone who volunteered at the Gold Coast Memory Walk & Jog. 

 

“It is only through the hard work of our wonderful volunteers that the success of this event is possible.”

 

This event was one of 28 Memory Walk & Jog events held across Australia in 2025. Each event offers a wonderful opportunity for people impacted by dementia and their supporters to come together, walk or run, at any fitness level, and to raise money and share stories.

  

Missed this event but want to be involved? Organise your own group or individual walk or jog, with a MyWay event. Choose your own date and location and register at www.memorywalk.com.au/get-involved/mw. 

 

-Ends-

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 433,300 Australians living with dementia, and the more than 1.7 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

Media contacts: Teresa Cong, Senior Media & Communications Advisor, [email protected], 0423 383 564

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

Photos and video of previous Memory Walk & Jog events for publication are available for use.

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Medical Health Aged Care
  • 12/04/2026
  • 07:10
Energy Enhancement System

Court Rules Against Jason Shurka in EESystem Case; $54,034 in Federal Sanctions Ordered

Clark County judge finds defendant’s public statements were not made in good faith. The ruling caps months of legal proceedings brought by the inventor…

  • Contains:
  • Medical Health Aged Care
  • 12/04/2026
  • 06:25
Royal Australian College of GPs

Cleanbill report shows bulk billing rises where funding is strongest, not where competition is greatest

The Royal Australian College of General Practitioners (RACGP) says new Cleanbill data indicates what GPs have consistently warned is true: bulk billing increases where funding better reflects the true cost of care, not where there is greater competition between practices. The Cleanbill report, released today, breaks down bulk billing and gap fees by how rural a practice is based on Modified Monash Model (MM1–7) classification. It shows that the largest increases in 100% bulk billing have occurred in regional and rural areas where government incentives are highest, yet where health department data show there are fewer GPs per person. RACGP…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 10/04/2026
  • 11:12
Aravax

Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby

Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifyingimmunotherapies for food allergy, today announces two additions to its Board of Directors, former CEO of ALK-Abello A/S, Carsten Hellmann and former Chief Commercial Officer of Aimmune Therapeutics, Andrew Oxtoby. Collectively, Carsten and Andrew bring to Aravax exceptionally deep experience from the pharmaceutical industry and, specifically, the allergy therapeutics field. Andrew has deep pharmaceutical industry expertise spanning development, product launch, fundraising and exits from working with large and small companies in the U.S. and Europe. As Chief Commercial Officer he built the global commercial organisation for the approval and launch in the US…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.